References
- Baskar, G.; Sree, N. S. Anticancer Activity of Gelatin-Asparaginase Nanobiocomposite against Cervical and Brain Cancer Cell Lines. J. Drug. Deliv. Sci. Technol. 2020, 57, 101689. DOI: https://doi.org/10.1016/j.jddst.2020.101689.
- Saeed, H.; Soudan, H.; El-Sharkawy, A.; Farag, A.; Embaby, A.; Ataya, F. Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant L.Asparaginase. Protein J. 2018, 37, 461–471. DOI: https://doi.org/10.1007/s10930-018-9789-3.
- Cecconello, D. K.; Magalhães, M. R. d.; Werlang, I. C. R.; Lee, M. L. d M.; Michalowski, M. B.; Daudt, L. E. Asparaginase: An Old Drug with New Questions. Hematol. Transfus. Cell Ther. 2020, 42, 275–282. DOI: https://doi.org/10.1016/j.htct.2019.07.010.
- Vettore, L.; Westbrook, R. L.; Tennant, D. A. New Aspects of Amino Acid Metabolism in Cancer. Br. J. Cancer 2020, 122, 150–156. DOI: https://doi.org/10.1038/s41416-019-0620-5.
- Mazloum-Ravasan, S.; Madadi, E.; Fathi, Z.; Mohammadi, A.; Mosafer, J.; Mansoori, B.; Mokhtarzadeh, A.; Baradaran, B.; Darvishi, F. The Effect of Yarrowia lipolytica L-Asparaginase on Apoptosis Induction and Inhibition of Growth in Burkitt’s Lymphoma Raji and Acute Lymphoblastic Leukemia MOLT-4 Cells. Int. J. Biol. Macromol. 2020, 146, 193–201. DOI: https://doi.org/10.1016/j.ijbiomac.2019.12.156.
- Kotzia, G. A.; Labrou, N. E. L-Asparaginase from Erwinia chrysanthemi 3937: Cloning, Expression and Characterization. J. Biotechnol. 2007, 127, 657–669. DOI: https://doi.org/10.1016/j.jbiotec.2006.07.037.
- Müller, H. J.; Boos, J. Use of L-Asparaginase in Childhood ALL. Crit. Rev. Oncol. Hematol. 1998, 28, 97–113. DOI: https://doi.org/10.1016/s1040-8428(98)00015-8.
- Avramis, V. I.; Tiwari, P. N. Asparaginase (Native ASNase or Pegylated ASNase) in the Treatment of Acute Lymphoblastic Leukemia. Int. J. Nanomedicine 2006, 1, 241–254.
- Burke, M. J. How to Manage Asparaginase Hypersensitivity in Acute Lymphoblastic Leukemia. Future Oncol. 2014, 10, 2615–2627. DOI: https://doi.org/10.2217/fon.14.138.
- Schalk, A. M.; Antansijevic, A.; Caffrey, M.; Lavie, A. Experimental Data in Support of a Direct Displacement Mechanism for Type I/II L-Asparaginase Isozymes of Escherichia coli. J. Biol. Chem. 2016, 291, 5088–5100. DOI: https://doi.org/10.1074/jbc.M115.699884.
- Srikhanta, Y. N.; Atack, J. M.; Beacham, I. R.; Jennings, M. P. Distinct Physiological Roles for the Two L-Asparaginase Isozymes of Escherichia coli. Biochem. Biophys. Res. Commun. 2013, 436, 362–365. DOI: https://doi.org/10.1016/j.bbrc.2013.05.066.
- van der Sluis, I. M.; Vrooman, L. M.; Pieters, R.; Baruchel, A.; Escherich, G.; Goulden, N.; Mondelaers, V.; Sanchez de Toledo, J.; Rizzari, C.; Silverman, L. B.; Whitlock, J. A. Consensus Expert Recommendations for Identification and Management of Asparaginase Hypersensitivity and Silent Inactivation. Haematologica 2016, 101, 279–285. DOI: https://doi.org/10.3324/haematol.2015.137380.
- Reinert, R. B.; Oberle, L. M.; Wek, S. A.; Bunpo, P.; Wang, X. P.; Mileva, I.; Goodwin, L. O.; Aldrich, C. J.; Durden, D. L.; McNurlan, M. A.; et al. Role of Glutamine Depletion in Directing Tissue-Specific Nutrient Stress Responses to L-asparaginase. J. Biol. Chem. 2006, 281, 31222–31233. DOI: https://doi.org/10.1074/jbc.M604511200.
- Chan, W. K.; Lorenzi, P. L.; Anishkin, A.; Purwaha, P.; Rogers, D. M.; Sukharev, S.; Rempe, S. B.; Weinstein, J. N. The Glutaminase Activity of L-Asparaginase Is Not Required for Anticancer Activity Against ASNS-Negative-Cells. Blood 2014, 123, 3596–3606. DOI: https://doi.org/10.1182/blood-2013-10-535112.
- Sambrook, H. Molecular Cloning: A Laboratory Manual, 2nd ed.; Cold Spring Harbor Laboratory Press: New York; 1989.
- Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248–254. DOI: https://doi.org/10.1006/abio.1976.9999.
- Zuo, S.; Xue, D.; Zhang, T.; Jiang, B.; Mu, W. Biochemical Characterization of an Extremely Thermostable L-Asparaginase from Thermococcus gammatolerans EJ3. J. Mol. Cata. B: Enz. 2014, 109, 122–129. DOI: https://doi.org/10.1016/j.molcatb.2014.08.021.
- Laemmli, U. K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 1970, 227, 680–685. DOI: https://doi.org/10.1038/227680a0.
- Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic Transfer of Proteins from Polyacrylamide Gels to Nitrocellulose Sheets: Procedure and Some Applications. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 4350–4354. [Database] DOI: https://doi.org/10.1073/pnas.76.9.4350.
- Lee, C. H.; Tsai, C. M. Quantification of Bacterial Lipopolysaccharide by the Purpald Assay: Measuring Formaldehyde Generated from 2-Keto-3-Deoxyoctonate and Heptose at the Inner Cre by Periodate Oxidation. Anal. Biochem. 1999, 267, 161–168. DOI: https://doi.org/10.1006/abio.1998.2961.
- Saeed, H.; Hemida, A.; El-Nikhely, N.; Abdel-Fattah, M.; Shalaby, M.; Hussein, A.; Eldoksh, A.; Ataya, F.; Aly, N.; Labrou, N.; Nematalla, H. Highly Efficient Pyrococcus furiosus Recombinant L-Asparaginase with No Glutaminase Activity: Expression, Purification, Functional Characterization, and Cytotoxicity on THP-1, A549 and Caco-2 cell lines. Int. J. Biol. Macromol. 2020, 156, 812–828. DOI: https://doi.org/10.1016/j.ijbiomac.2020.04.080.
- Rampersad, S. N. Multiple Applications of Alamar Blue as an Indicator of Metabolic Function and Cellular Health in Cell Viability Bioassays. Sensors 2012, 12, 12347–12360. DOI: https://doi.org/10.3390/s120912347.
- Strober, W. Trypan Blue Exclusion Test of Cell Viability. Curr. Protoc. Immunol. 2015, 111, A3.B1–A3.B3.
- van de Loosdrecht, A. A.; Nennie, E.; Ossenkoppele, G. J.; Beelen, R. H.; Langenhuijsen, M. M. Cell Mediated Cytotoxicity against U 937 Cells by Human Monocytes and Macrophages in a Modified Colorimetric MTT Assay: A Methodological Study. J. Immunol. Methods 1991, 141, 15–22. DOI: https://doi.org/10.1016/0022-1759(91)90205-T.
- Panosyan, E. H.; Grigoryan, R. S.; Avramis, I. A.; Seibel, N. L.; Gaynon, P. S.; Siegel, S. E. Deamination of Glutamine is a Prerequisite for Optimal Asparagine Deamination by L-Asparaginases In Vivo (CCG-1961). Anticancer Res. 2004, 24, 1121–1126.
- Ollenschläger, G.; Roth, E.; Linkesch, W.; Jansen, S.; Simmel, A.; Mödder, B. L-Asparaginase‐Induced Derangements of Glutamine Metabolism: The Pathogenetic Basis for Some Drug‐Related Side‐Effects. Eur. J. Clin. Invest. 1988, 18, 512–516. DOI: https://doi.org/10.1111/j.1365-2362.1988.tb01049.x.
- Schwarz, E. C.; Qu, B.; Hoth, M. Calcium, Cancer and Killing: The Role of Calcium in Killing Cancer Cells by Cytotoxic T-Lymphocytes and Natural Killer Cells. Biochem. Biophys. Acta BBA- Mol. Cell. Res. 2013, 1833, 1603–1611. DOI: https://doi.org/10.1016/j.bbamcr.2012.11.016.
- Cooney, D.; Capizzi, R.; Handschumacher, R. Evaluation of L-Asparagine Metabolism in Animals and Man. Cancer Res. 1979, 30, 929–935.
- Kato, M.; Manabe, M. Treatment and Biology of Pediatric Acute Lymphoblastic Leukemia. Pediatr. Int. 2018, 60, 4–12. DOI: https://doi.org/10.1111/ped.13457.
- Raetz, E. A.; Salzer, W. L. Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia. J. Pediatr. Hematol. Oncol. 2010, 32, 554–563. DOI: https://doi.org/10.1097/MPH.0b013e3181e6f003.
- Shinnick, S. E.; Browning, M. L.; Koontz, S. E. Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults. J. Pediatr. Oncol. Nurs. 2013, 30, 63–77. DOI: https://doi.org/10.1177/1043454212471728.
- Salzer, W.; Bostrom, B.; Messinger, Y.; Perissinotti, A. J.; Marini, B. Asparaginase Activity Levels and Monitoring in Patients with Acute Lymphoblastic Leukemia. Leuk. Lymphoma 2018, 59, 1797–1806. DOI: https://doi.org/10.1080/10428194.2017.1386305.
- Naumann, S.; Reutzel, D.; Speicher, M.; Decker, H. J. Complete Karyotype Characterization of the K562 Cell Line by Combined Application of G-Banding, Multiplex-Fluorescence In Situ Hybridization, Fluorescence In Situ Hybridization, and Comparative Genomic Hybridization. Leuk. Res. 2001, 25, 313–322. [Database] DOI: https://doi.org/10.1016/s0145-2126(00)00125-9.
- Facchinetti de Castro Girão, L.; Gonçalves da Rocha, S. L.; Sobral, R. S.; Dinis Ano Bom, A. P.; Franco Sampaio, A. L.; Godinho da Silva, J.; Ferrara, M. A.; Pinto da Silva Bon, E.; Perales, J. Saccharomyces cerevisiae Asparaginase II, a Potential Antileukemic Drug: purification and Characterization of the Enzyme Expressed in Pichia pastoris. Protein Expr. Purif. 2016, 120, 118–125. DOI: https://doi.org/10.1016/j.pep.2015.12.012.
- Oltvai, Z. N.; Milliman, C. L.; Korsmeyer, S. J. Bcl-2 Heterodimerizes In Vivo with a Conserved Homolog, Bax, That Accelerates Programmed Cell Death. Cell 1993, 74, 609–619. DOI: https://doi.org/10.1016/0092-8674(93)90509-o.
- Gerdes, J.; Li, L.; Schlueter, C.; Duchrow, M.; Wohlenberg, C.; Gerlach, C. Immunochemical and Molecular Biologic Characterization of the Cell Proliferation-Associated Nuclear Antigen That is Defined by Monoclonal Antibody Ki-67. Am. J. Pathol. 1991, 138, 867–873.
- Shin, S.; Sung, B.-J.; Cho, Y.-S.; Kim, H.-J.; Ha, N.-C.; Hwang, J.-I.; Chung, C.-W.; Jung, Y.-K.; Oh, B.-H. An Antiapoptotic Protein Human Survivin is a Direct Inhibitor of Caspase-3 and 7. Biochemistry 2001, 40, 1117–1123. DOI: https://doi.org/10.1021/bi001603q.
- Palavecino, C. E.; Carrasco-Véliz, N.; Quest, A. F. G.; Garrido, M. P.; Valenzuela-Valderrama, M. The 5' Untranslated Region of the Anti-Apoptotic Protein Survivin Contains an Inhibitory Upstream AUG Codon. Biochem. Biophys. Res. Commun. 2020, 526, 898–905. DOI: https://doi.org/10.1016/j.bbrc.2020.03.160.
- Kamal, N.; Koh, C.; Samala, N.; Fontana, R. J.; Stolz, A.; Durazo, F.; Hayashi, P. H.; Phillips, E.; Wang, T.; Hoofnagle, J. H. Asparaginase-Induced Hepatotoxicity: Rapid Development of Cholestasis and Hepatic Steatosis. Hepatol. Int. 2019, 13, 641–648. DOI: https://doi.org/10.1007/s12072-019-09971-2.
- Egler, R. A.; Ahuja, S. P.; Matloub, Y. L-Asparaginase in the Treatment of Patients with Acute Lymphoblastic Leukemia. J. Pharmacol. Pharmacother. 2016, 7, 62–71. DOI: https://doi.org/10.4103/0976-500X.184769.
- Raja, R. A.; Schmiegelow, K.; Frandsen, T. L. Asparaginase-Associated Pancreatitis in Children. Br. J. Haematol. 2012, 159, 18–27. [Database] DOI: https://doi.org/10.1111/bjh.12016.
- Kearney, S. L.; Dahlberg, S. E.; Levy, D. E.; Voss, S. D.; Sallan, S. E.; Silverman, L. B. Clinical Course and Outcome in Children with Acute Lymphoblastic Leukemia and Asparaginase-Associated Pancreatitis. Pediatr. Blood Cancer 2009, 53, 162–167. DOI: https://doi.org/10.1002/pbc.22076.